EarningsQ4 2023 Earnings Report

Arrowhead Pharmaceuticals (ARWR) Q4 2023 Earnings Report

0 Followers

MX:ARWR Q4 2023 EPS Results

Actual EPS-$18.53

Consensus EPS-$11.06

Beat/MissMissed by -$7.46

One Year Ago EPS-$14.53

Actual Revenue$292.36M

Expected Revenue$810.64M

Beat/MissMissed by -$518.28M

YoY Revenue Growth-49.02%

QuarterQ4 2023

Date11/29/2023

TimeAfter Close

Conference CallWednesday, November 29, 2023

MX:ARWR Upcoming Earnings

Arrowhead Pharmaceuticals's next earnings date is estimated for November 30, 2026, based on past reporting schedules.

MX:ARWR Q4 2023 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 30, 2026	2026 (Q4)	-28.17 / -	-1.998	―
Aug 04, 2026	2026 (Q3)	-23.19 / -24.70	-22.885	-7.94% (-1.82)
May 07, 2026	2026 (Q2)	-19.89 / -16.89	49.946	-133.82% (-66.84)
Feb 05, 2026	2026 (Q1)	0.67 / 4.00	-25.246	115.83% (+29.24)
Nov 25, 2025	2025 (Q4)	-2.03 / -2.00	-24.701	91.91% (+22.70)
Aug 07, 2025	2025 (Q3)	-17.29 / -22.88	-25.064	8.70% (+2.18)
May 12, 2025	2025 (Q2)	-3.40 / 49.95	-18.526	369.61% (+68.47)
Feb 10, 2025	2025 (Q1)	-8.65 / -25.25	-22.521	-12.10% (-2.72)
Nov 26, 2024	2024 (Q4)	-20.34 / -24.70	-18.526	-33.33% (-6.18)
Aug 08, 2024	2024 (Q3)	-9.61 / -25.06	-17.436	-43.75% (-7.63)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed